• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PNPLA3 I148M的性别特异性影响。

Sex-specific effects of PNPLA3 I148M.

作者信息

Cherubini Alessandro, Rosso Chiara, Della Torre Sara

机构信息

Department of Transfusion Medicine, Precision Medicine-Biological Resource Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Department of Medical Sciences, University of Turin, Turin, Italy.

出版信息

Liver Int. 2025 Mar;45(3):e16088. doi: 10.1111/liv.16088. Epub 2024 Sep 11.

DOI:10.1111/liv.16088
PMID:39262132
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11815604/
Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD, previously termed NAFLD, nonalcoholic fatty liver disease) is a complex multifactorial disease showing generally higher prevalence and severity in men than in women. With respect to women, men are also more prone to develop metabolic dysfunction-associated steatohepatitis, fibrosis and liver-related complications. Several genetic, hormonal, environmental and lifestyle factors may contribute to sex differences in MASLD development, progression and outcomes. However, after menopause, the sex-specific prevalence of MASLD shows an opposite trend between men and women, pointing to the relevance of oestrogen signalling in the sexual dimorphism of MASLD. The patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene, that encodes a triacylglycerol lipase that plays a crucial role in lipid metabolism, has emerged as a key player in the pathogenesis of MASLD, with the I148M variant being strongly associated with increased liver fat content and disease severity. Recent advances indicate that carrying the PNPLA3 I148M variant can be a risk factor for MASLD especially for women. To elucidate the molecular mechanisms underlying the sex-specific role of PNPLA3 I148M in the development of MASLD, several in vitro, ex vivo and in vivo models have been developed.

摘要

代谢功能障碍相关脂肪性肝病(MASLD,以前称为非酒精性脂肪性肝病,NAFLD)是一种复杂的多因素疾病,通常男性的患病率和严重程度高于女性。在女性方面,男性也更容易发展为代谢功能障碍相关脂肪性肝炎、肝纤维化及肝脏相关并发症。一些遗传、激素、环境和生活方式因素可能导致MASLD在发生、发展和预后方面存在性别差异。然而,绝经后,MASLD的性别特异性患病率在男性和女性之间呈现相反趋势,这表明雌激素信号传导在MASLD的性别二态性中具有重要意义。含帕他汀样磷脂酶结构域蛋白3(PNPLA3)基因编码一种在脂质代谢中起关键作用的三酰甘油脂肪酶,已成为MASLD发病机制中的关键因素,I148M变异与肝脏脂肪含量增加和疾病严重程度密切相关。最近的研究进展表明,携带PNPLA3 I148M变异可能是MASLD的一个危险因素,尤其是对女性而言。为了阐明PNPLA3 I148M在MASLD发生过程中性别特异性作用的分子机制,已经建立了多种体外、离体和体内模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bb7/11815604/24c5b3b14473/LIV-45-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bb7/11815604/24c5b3b14473/LIV-45-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bb7/11815604/24c5b3b14473/LIV-45-0-g001.jpg

相似文献

1
Sex-specific effects of PNPLA3 I148M.PNPLA3 I148M的性别特异性影响。
Liver Int. 2025 Mar;45(3):e16088. doi: 10.1111/liv.16088. Epub 2024 Sep 11.
2
A novel human hepatocyte cell line to study PNPLA3-associated steatotic liver disease.一种用于研究PNPLA3相关脂肪性肝病的新型人肝细胞系。
Am J Physiol Gastrointest Liver Physiol. 2025 Jul 1;329(1):G1-G16. doi: 10.1152/ajpgi.00193.2024. Epub 2025 Apr 23.
3
PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease.PNPLA3 I148M与环境触发因素相互作用导致人类疾病。
Liver Int. 2025 Mar;45(3):e16106. doi: 10.1111/liv.16106. Epub 2024 Nov 19.
4
Lipid droplet targeting of the lipase coactivator ABHD5 and the fatty liver disease-causing variant PNPLA3 I148M is required to promote liver steatosis.脂肪酶共激活因子ABHD5和导致脂肪肝疾病的变体PNPLA3 I148M的脂滴靶向作用是促进肝脏脂肪变性所必需的。
J Biol Chem. 2025 Feb;301(2):108186. doi: 10.1016/j.jbc.2025.108186. Epub 2025 Jan 13.
5
Statin-associated regulation of hepatic PNPLA3 in patients without known liver disease.无已知肝脏疾病患者中他汀类药物相关的肝脏PNPLA3调节
J Intern Med. 2025 Jan;297(1):47-59. doi: 10.1111/joim.20032. Epub 2024 Nov 19.
6
PNPLA3 I148M and Hepatocellular Carcinoma.PNPLA3 I148M与肝细胞癌
Liver Int. 2025 Apr;45(4):e70051. doi: 10.1111/liv.70051.
7
Role of PNPLA3 in Hepatic Stellate Cells and Hepatic Cellular Crosstalk.PNPLA3在肝星状细胞及肝细胞相互作用中的作用
Liver Int. 2025 Apr;45(4):e16117. doi: 10.1111/liv.16117. Epub 2024 Oct 12.
8
Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant.代谢功能障碍相关脂肪性肝病中激活素 A 水平与纤维化及 PNPLA3 I148M 变异体相关。
Scand J Gastroenterol. 2024 Jun;59(6):737-741. doi: 10.1080/00365521.2024.2334804. Epub 2024 Apr 2.
9
PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.非酒精性脂肪性肝病中的PNPLA3 I148M变异:人口统计学和种族特征以及该变异在非酒精性脂肪性肝纤维化中的作用
World J Gastroenterol. 2015 Jan 21;21(3):794-802. doi: 10.3748/wjg.v21.i3.794.
10
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.导致脂肪肝疾病的蛋白质PNPLA3-I148M改变脂滴-高尔基体动力学。
Proc Natl Acad Sci U S A. 2024 Apr 30;121(18):e2318619121. doi: 10.1073/pnas.2318619121. Epub 2024 Apr 24.

引用本文的文献

1
Fifteen Years of PNPLA3: Transforming Hepatology Through Human Genetics.PNPLA3的十五年:通过人类遗传学改变肝病学
Liver Int. 2025 Sep;45(9):e70240. doi: 10.1111/liv.70240.
2
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women.绝经后女性的代谢功能障碍相关脂肪性肝病:患病率、发病机制及基于性别的治疗方法
Biomedicines. 2025 Apr 2;13(4):855. doi: 10.3390/biomedicines13040855.
3
Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis.女性高密度脂蛋白胆固醇水平低和男性高甘油三酯血症:无脂肪变性个体中代谢相关脂肪性肝病发病的预测因素。

本文引用的文献

1
Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的性别二态性。
Trends Mol Med. 2024 Dec;30(12):1126-1136. doi: 10.1016/j.molmed.2024.05.013. Epub 2024 Jun 17.
2
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD).基于与人类代谢功能障碍相关的脂肪性肝病 (MASLD) 的接近程度,对鼠类饮食模型进行无偏排序。
Nat Metab. 2024 Jun;6(6):1178-1196. doi: 10.1038/s42255-024-01043-6. Epub 2024 Jun 12.
3
PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein.
J Gastroenterol. 2025 Mar 18. doi: 10.1007/s00535-025-02242-y.
4
Impact of Sexual Dimorphism on Therapy Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: From Conventional and Nutritional Approaches to Emerging Therapies.性别差异对代谢功能障碍相关脂肪性肝病患者治疗反应的影响:从传统和营养方法到新兴疗法
Nutrients. 2025 Jan 28;17(3):477. doi: 10.3390/nu17030477.
载脂蛋白 PLA3 是一种甘油三酯脂肪酶,可动员多不饱和脂肪酸,促进大颗粒极低密度脂蛋白从肝脏中输出。
Nat Commun. 2024 Jun 6;15(1):4847. doi: 10.1038/s41467-024-49224-x.
4
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.雌激素受体-α与 PNPLA3 p.I148M 变异体的相互作用导致女性患脂肪肝疾病的易感性。
Nat Med. 2023 Oct;29(10):2643-2655. doi: 10.1038/s41591-023-02553-8. Epub 2023 Sep 25.
5
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease.载脂蛋白基因 3 多态性 rs738409 对非酒精性脂肪性肝病患者肝脏相关事件发生的影响。
Clin Gastroenterol Hepatol. 2023 Dec;21(13):3314-3321.e3. doi: 10.1016/j.cgh.2023.04.024. Epub 2023 May 4.
6
Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research.遗传和饮食诱导的非酒精性脂肪性肝病(NAFLD)动物模型研究。
Int J Mol Sci. 2022 Dec 13;23(24):15791. doi: 10.3390/ijms232415791.
7
Dietary essential amino acids restore liver metabolism in ovariectomized mice via hepatic estrogen receptor α.饮食必需氨基酸通过肝脏雌激素受体 α 恢复去卵巢小鼠的肝脏代谢。
Nat Commun. 2021 Nov 25;12(1):6883. doi: 10.1038/s41467-021-27272-x.
8
Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology.超越 X 因素:性激素在非酒精性脂肪性肝病发病机制中的相关性。
Cells. 2021 Sep 21;10(9):2502. doi: 10.3390/cells10092502.
9
Hepatic sexual dimorphism - implications for non-alcoholic fatty liver disease.肝脏的性别差异——对非酒精性脂肪性肝病的影响
Nat Rev Endocrinol. 2021 Nov;17(11):662-670. doi: 10.1038/s41574-021-00538-6. Epub 2021 Aug 20.
10
Selective estrogen receptor modulators (SERMs) affect cholesterol homeostasis through the master regulators SREBP and LXR.选择性雌激素受体调节剂 (SERMs) 通过主调控因子 SREBP 和 LXR 影响胆固醇稳态。
Biomed Pharmacother. 2021 Sep;141:111871. doi: 10.1016/j.biopha.2021.111871. Epub 2021 Jul 3.